CN101342286B - Chinese medicinal composition for treating protrusion of lumbar vertebral disc and hyperosteogeny - Google Patents
Chinese medicinal composition for treating protrusion of lumbar vertebral disc and hyperosteogeny Download PDFInfo
- Publication number
- CN101342286B CN101342286B CN2008101464826A CN200810146482A CN101342286B CN 101342286 B CN101342286 B CN 101342286B CN 2008101464826 A CN2008101464826 A CN 2008101464826A CN 200810146482 A CN200810146482 A CN 200810146482A CN 101342286 B CN101342286 B CN 101342286B
- Authority
- CN
- China
- Prior art keywords
- hyperosteogeny
- portions
- intervertebral disc
- lumbar intervertebral
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a Chinese medicinal composition which is used for treating the proplapse of lumbar intervertebral disc and Hyperosteogeny. The composition is prepared from raw materials according to the following weight portions: 5 portions of saffron, 20 portions of dragon blood, 10 portions of soil insects, 5 portions of frankincense, 5 portions of myrrh and 0.5 portion of borneol. The composition has the functions of activating blood circulation, dissipating blood stasis, promoting qi, eliminating pains, dispelling wind, eliminating dampness, dredging collaterals and stopping pains, and has excellent effects on treatment of the proplapse of lumbar intervertebral disc and the Hyperosteogeny.
Description
Technical field
The present invention relates to field of medicaments, specifically, the present invention relates to a kind of Chinese medicine composition of treating prolapse of lumbar intervertebral disc and hyperosteogeny.
Background technology
Prolapse of lumbar intervertebral disc is a kind of commonly encountered diseases, frequently-occurring disease, and the trend that increases is year by year arranged.Its morbidity is to be broken by the fibrous ring of lumbar intervertebral disc, and vertebral pulp is outstanding, compressing dural sac, nerve root and cause.Prolapse of lumbar intervertebral disc have two kinds, a kind of is sudden prolapse of lumbar intervertebral disc, another kind is the potentiality prolapse of lumbar intervertebral disc.Paroxysmal is to bear the pressure of over loading by wound or waist and cause intervertebral disk hernia or extrude.The potentiality prolapse of lumbar intervertebral disc is hypertrophy, the intervertebral disk retrogression pathological changes because of vertebral body; The unstability or the subluxation of the intervertebral disc inflammatory reaction twisting of joints; Lumbar vertebra lateral bending and cause multilevel twisting of joints unstability; And latency such as the fragile degeneration of the fibrous ring that causes of Inheritance property causes, no matter is sudden prolapse of lumbar intervertebral disc or potentiality prolapse of lumbar intervertebral disc, all brings harm and painful to the patient.
The arthromyodynia category of the primary disease ownership traditional Chinese medical science.Chinese medicine thinks, the wind-cold damp pathogen invasion and attack, and acute and chronic trauma causes meridians impatency, QI-blood circulation smooth and cause a disease, so forefathers have " numbness person closes also ", the saying of " bitterly then obstructed, general rule is not bitterly ".The primary disease primary symptom is a lumbago and skelalgia, and it causes the machine-processed more complicated of lumbago and skelalgia, but mainly is mechanical pressure and two aspects of chemical stimulation.Mechanical pressure occurs formerly, after chemical stimulation occurs in.Aseptic inflammations such as the compressing of outthrust stimulates can cause nerve root hyperemia, ooze out, edema, degeneration, adhesion are secreted algogenic substances such as Kallidin I then.
A large amount of cases prove that prolapse of lumbar intervertebral disc is easy to make a definite diagnosis through means such as X-ray, CT, magnetic resonance.To the treatment of prolapse of lumbar intervertebral disc, at present doctor trained in Western medicine with traction, computer reset, methods treatments such as canalis sacralis therapy, operation, the traditional Chinese medical science is treated with methods such as acupuncture, cupping, massage, extract orals.Though said method can alleviate mechanical pressure effectively, it can not eliminate chemical stimulation effectively, remove the swelling and the congestion pain in partial wind-cold damp pathogen and affected part, and the course of treatment is longer.
Summary of the invention
The purpose of this invention is to provide a kind of Chinese medicine composition of treating prolapse of lumbar intervertebral disc and hyperosteogeny.
In order to realize the object of the invention; The present invention provides a kind of Chinese medicine composition of treating prolapse of lumbar intervertebral disc and hyperosteogeny, and it is the medicament of being processed according to weight portion by following bulk drugs: 0.5 part of 5 parts of Stigma Crocis, 20 parts of Sanguis Draxonis, 10 parts of eupolyphage sece steleophagas, 5 parts of Olibanums, 5 parts of Myrrhas and Borneolum Syntheticum.Wherein Stigma Croci has the effect of blood circulation promoting and blood stasis dispelling, collateral dredging; Sanguis Draxonis has clots absorbing, analgesic effect; Eupolyphage sece steleophaga has the effect of removing blood stasis, reunion of fractured tendons and bones; Olibanum has the effect of blood-activating and qi-promoting, reducing swelling and alleviating pain; Myrrha has the effect of blood-activating and qi-promoting, reducing swelling and alleviating pain; Borneolum Syntheticum has the effect of the analepsia of having one's ideas straightened out, clearing away heat to alleviate pain.
Said pharmacy optimization is a plaster.
Chinese medicine composition of the present invention has blood circulation promoting and blood stasis dispelling, promoting the circulation of QI to relieve pain, and expelling wind and removing dampness, the effect of removing obstruction in the collateral to relieve pain has good effect to treatment prolapse of lumbar intervertebral disc and hyperosteogeny.
The specific embodiment
Following examples are used to explain the present invention, but are not used for limiting scope of the present invention.
Embodiment 1
Get Stigma Croci 5 grams, Sanguis Draxonis 20 grams, eupolyphage sece steleophaga 10 grams, Olibanum 5 grams, Myrrha 5 grams and Borneolum Syntheticum 0.5 gram, pulverize, cross 80 mesh sieves and make powder.Semen Ricini 50 restrained into add above-mentioned powder behind the pasty state, smash into paste, be divided into 10 and paste.
Experimental example
1, clinical data
1.1, physical data
Among the 80 routine patients, male 56 examples, women 24 examples: 25 years old~75 years old age; The course of disease did not wait in 1 month-10 years; 28 examples of companion's lumbar vertebra hyperosteogeny, 10 examples of companion's spinal canal stenosis.
1.2, diagnostic criteria
With reference to formulating about the diagnostic criteria of prolapse of lumbar intervertebral disc in " traditional Chinese medical science disease diagnosis criterion of therapeutical effect "; All case all has typical long-term chronic back pain history, and the companion begins to lower limb radiating pain or numbness, scoliosis from buttocks; The waist physiologic radian disappears, and straight-leg raising test is positive.All case is all done the lumbar vertebra CT examination, shows: prolapse of lumbar intervertebral disc.
2, Therapeutic Method
2.1, medicine
Prepare plaster according to embodiment 1 described method.
2.2, method for using
Plaster is spread on painful area, changed once 20 days courses of treatment, totally 2 courses of treatment in 2 days.Forbid taking maror during the drug of topical application, forbid drinking.
3, criterion of therapeutical effect
With reference to formulating about the criterion of therapeutical effect of prolapse of lumbar intervertebral disc in " traditional Chinese medical science disease diagnosis criterion of therapeutical effect ".
Clinical recovery: the complete obiteration of lumbago and skelalgia symptom, upright walking freely, have a medical check-up: straight-leg raising test 70 degree, can recover former work; Take a turn for the better: the lumbago and skelalgia sx, the waist movable function improves; Heal in the end: symptom and sign does not have improvement, straight-leg raising test 30 degree.
4, therapeutic outcome
72 examples of fully recovering, 8 examples that take a turn for the better, the end is 0 example more.
Claims (2)
1. Chinese medicine composition of treating prolapse of lumbar intervertebral disc and hyperosteogeny is characterized in that it is the medicament of being processed according to weight portion by following bulk drugs: 0.5 part of 5 parts of Stigma Crocis, 20 parts of Sanguis Draxonis, 10 parts of eupolyphage sece steleophagas, 5 parts of Olibanums, 5 parts of Myrrhas and Borneolum Syntheticum.
2. Chinese medicine composition according to claim 1 is characterized in that said medicament is a plaster.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008101464826A CN101342286B (en) | 2008-09-01 | 2008-09-01 | Chinese medicinal composition for treating protrusion of lumbar vertebral disc and hyperosteogeny |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008101464826A CN101342286B (en) | 2008-09-01 | 2008-09-01 | Chinese medicinal composition for treating protrusion of lumbar vertebral disc and hyperosteogeny |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101342286A CN101342286A (en) | 2009-01-14 |
CN101342286B true CN101342286B (en) | 2012-07-04 |
Family
ID=40244477
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008101464826A Expired - Fee Related CN101342286B (en) | 2008-09-01 | 2008-09-01 | Chinese medicinal composition for treating protrusion of lumbar vertebral disc and hyperosteogeny |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101342286B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104147289A (en) * | 2014-08-13 | 2014-11-19 | 刘天才 | Plaster for treatment of cervical and lumbar rheumatism hyperplasia |
CN106511685A (en) * | 2016-10-25 | 2017-03-22 | 王德福 | Muscle and bone hyperplasia treatment patch |
CN107095945A (en) * | 2017-04-01 | 2017-08-29 | 薛艳修 | It is a kind of to be used to treat ointment containing red precipitate of osteopathy and preparation method thereof |
CN109908246A (en) * | 2019-03-19 | 2019-06-21 | 亳州学院 | The external application Chinese medicine formula for treating lumbar pain orthopaedic disease |
CN110038077A (en) * | 2019-05-31 | 2019-07-23 | 王亮 | A kind of plaster for treating osteoproliferation, spur |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101129858A (en) * | 2007-08-27 | 2008-02-27 | 朱芳 | Plaster for treating cervical vertebra/lumbar disease |
CN101129681A (en) * | 2007-08-27 | 2008-02-27 | 朱芳 | Plaster for treating arthritis |
-
2008
- 2008-09-01 CN CN2008101464826A patent/CN101342286B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101129858A (en) * | 2007-08-27 | 2008-02-27 | 朱芳 | Plaster for treating cervical vertebra/lumbar disease |
CN101129681A (en) * | 2007-08-27 | 2008-02-27 | 朱芳 | Plaster for treating arthritis |
Also Published As
Publication number | Publication date |
---|---|
CN101342286A (en) | 2009-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1706441A (en) | Arthralgia treating plaster | |
CN101342286B (en) | Chinese medicinal composition for treating protrusion of lumbar vertebral disc and hyperosteogeny | |
CN1895549A (en) | Soothe tendons and activating-blood anodyne plaster | |
CN102908442B (en) | Composition for treating traumatic injuries and medicinal liquor thereof | |
CN1876084A (en) | Ointment for orthopedics | |
CN100998823A (en) | Plaster for treating osteosis, protrasion of lumbar intervertebral disc | |
CN102342983B (en) | Chinese medicinal composition for treating pain in the legs and numbness of the extremities and preparation method of preparation thereof | |
CN103463261B (en) | Traditional Chinese medicine preparation for treating lumbar intervertebral disc herniation | |
CN1255169C (en) | Medicine for relaxing muscles and tendons and activiating colleterals and pain dispelling | |
CN1135909A (en) | Medicine for hyperosteogeny and wind-cold syndrome | |
CN102526482A (en) | Traditional Chinese medicine preparation for treating lumbar disc herniation | |
CN104587226A (en) | Traditional Chinese medicine for treating ankylosing myelitis and lumbar disc herniation and use method thereof | |
CN104800463A (en) | Plaster for orthopaedics | |
CN101244135A (en) | Medicine label for treating rheumatism, hyperosteogeny | |
CN101214346B (en) | Chinese medicine emplastrum for treating pain of vertebrae cervicables lumbar intervertebral disc | |
CN104223873B (en) | A kind of Traditional Chinese medicine health care pillow and preparation method thereof | |
CN103656078A (en) | Traditional Chinese medicine for treating bone diseases | |
CN102319316B (en) | Rapid bone hyperplasia healing agent | |
CN103211867A (en) | External traditional Chinese medicine composition used for treating sprain | |
CN102614350A (en) | Chinese medicine for treating cervical spondylosis | |
CN100509052C (en) | Traditional Chinese medicine for treating bone medullitis | |
CN101954043A (en) | Medicament for treating hyperosteogeny and preparation method thereof | |
CN106620104A (en) | External plaster for treating removing dampness and relieving pain and preparation method thereof | |
CN1864722A (en) | A pharmaceutical composition for treating muscles and bones pain and lumbar intervertebral disc protrusion | |
CN106729400A (en) | A kind of exterior-applied medical wine for the treatment of of arthritis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Li Yumin Document name: Notification of Passing Preliminary Examination of the Application for Invention |
|
C06 | Publication | ||
PB01 | Publication | ||
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Li Yumin Document name: Notification of Publication of the Application for Invention |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120704 Termination date: 20190901 |
|
CF01 | Termination of patent right due to non-payment of annual fee |